Skip to content
healthcare.dev

TYKERB

NDC 0078-0671, lapatinib, tablet, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0671
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022059
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0671 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAPATINIB DITOSYLATE250 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0078-0671-1900078067119150 TABLET in 1 BOTTLE (0078-0671-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eee37f88-ec6a-4c30-b8aa-e2c71f93088c

Use it

Look up 0078-0671 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0671 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0671. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.